Location
lysaker
Posted
June 10, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
**Population Health Specialist-Norway**:
**Location: Norway/Lysaker**:
**About the Job**:
As the Population Health Specialist for aT1D in D, you will be primarily responsible to drive the Global people-at-risk screening, monitoring & infrastructure strategy in Denmark for a first-in-class therapy in Autoimmune Type 1 Diabetes. Reporting to the Population Health Strategy Lead for North Europe, this role is positioned to realize the ambition for T1D and contribute to the overall future success of Sanofi. The position will belong to a team of Population Health Specialists, each of whom will be responsible for covering different areas across North Europe.
**The Opportunity**:
Join our groundbreaking new team of Population Health Specialists in North Europe for the launch of our first-in-class transformative therapy in Autoimmune Type 1 Diabetes (AT1D). This role offers the unique opportunity to accelerate early diagnosis of AT1D and shape the future of diabetes care in Norwa...
**Location: Norway/Lysaker**:
**About the Job**:
As the Population Health Specialist for aT1D in D, you will be primarily responsible to drive the Global people-at-risk screening, monitoring & infrastructure strategy in Denmark for a first-in-class therapy in Autoimmune Type 1 Diabetes. Reporting to the Population Health Strategy Lead for North Europe, this role is positioned to realize the ambition for T1D and contribute to the overall future success of Sanofi. The position will belong to a team of Population Health Specialists, each of whom will be responsible for covering different areas across North Europe.
**The Opportunity**:
Join our groundbreaking new team of Population Health Specialists in North Europe for the launch of our first-in-class transformative therapy in Autoimmune Type 1 Diabetes (AT1D). This role offers the unique opportunity to accelerate early diagnosis of AT1D and shape the future of diabetes care in Norwa...